why post negative s**t stockanalystin a few weeks - AED will be a cashcowstop trying to freak the newbies into giving their shares away
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling